Condition: Persistent Spinal Pain Syndrome Type 2 · Failed Back Surgery Syndrome · Sponsor: Rijnstate Hospital
Spinal cord stimulation (SCS) has shown to be an effective treatment for patients with persistent spinal pain syndrome Type 2 (PSPS Type 2). The method used to deliver electrical charge in SCS is important. One such method is burst stimulation. Two variations of burst waveforms are currently in use: one that employs active recharge and one that uses passive recharge. It is still unknown if there are clinical differences between active recharge and passive recharge burst SCS. To date, no clinical studies have been performed that directly compared these two burst stimulation waveforms. The objective of this Randomized Clinical Trial (RCT) is to assess and compare effect of passive recharge burst SCS with active recharge burst SCS on pain relief and motivational-emotional facets of pain
This description comes directly from the study's public registry record.
Martijn Mons, Msc. · +31433881034 · m.mons@maastrichtuniversity.nl
Jan-Willem Kallewaard, PhD · jkallewaard@rijnstate.nl
Always discuss trial participation with your own doctor first.
| Rijnstate Hospital | Arnhem, Gelderland, Netherlands | Recruiting |
| Bravis Hospital | Roosendaal, North Brabant, Netherlands | Recruiting |
| Elizabeth TweeSteden Hospital | Tilburg, North Brabant, Netherlands | Recruiting |
| Amsterdam University Medical Hospitals A-UMC | Amsterdam, North Holland, Netherlands | Recruiting |
| Alrijne Hospital | Leiderdorp, South Holland, Netherlands | Not Yet Recruiting |
| Diakonessen Hospital | Zeist, Utrecht, Netherlands | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05421273